Showing results (131-140 of 269) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|December 5, 2018
Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumoursSue Zann Lim, Cedric Chuan Young Ng, Vikneswari Rajasegaran, et al.
Cancer Research|November 20, 2002
Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical featuresMasayuki Takahashi, Ximing J Yang, Todd T Lavery, et al.
Developmental Cell|August 1, 2024
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitorsShen Yon Toh, Hui Sun Leong, Fui Teen Chong, et al.
Communications Biology|October 12, 2019
Digital phenotyping by consumer wearables identifies sleep-associated markers of cardiovascular disease risk and biological agingJing Xian Teo, Sonia Davila, Chengxi Yang, et al.
Nature Genetics|October 10, 2017
The draft genome of tropical fruit durian (Durio zibethinus)Bin Tean Teh, Kevin Lim, Chern Han Yong, et al.
International Journal of Oncology|August 2, 2018
Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau diseaseCharles-Henry Gattolliat, Sophie Couvé, Guillaume Meurice, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 4, 2023
Muscle Injuries Induce a Prostacyclin-PPARγ/PGC1a-FAO Spike That Boosts RegenerationLanfang Luo, Yan-Jiang Benjamin Chua, Taoyan Liu, et al.
Oncology Letters|October 29, 2021
Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathwaySophie Gad, Gwenaël Le Teuff, Baptiste Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinomaMin-Han Tan, Carl Morrison, Pengfei Wang, et al.
International Journal of Biological Sciences|June 16, 2025
PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinomaPeili Wang, Rong Xiao, Jianfeng Chen, et al.
Pageof 27